Abbott is teaming up with AtaCor Medical to develop a next-generation implantable cardioverter defibrillator (ICD) designed ...
San Clemente-based cardiac device company AtaCor Medical announced a collaboration with Abbott Laboratories to develop a next ...
Cardiac device therapy has significantly evolved since the introduction of the first implantable pacemaker and the subsequent ...
A Fort Worth hospital is participating in an international study to help more people survive cardiac arrest.
The subcutaneous implantable cardioverter–defibrillator (ICD) is associated with fewer lead-related complications than a transvenous ICD; however, the subcutaneous ICD cannot provide bradycardia and ...
Madrid, Spain – 30 August 2025: Prophylactic implantable cardioverter defibrillator therapy did not reduce mortality in patients with a prior myocardial infarction, persistent moderate left ...
CINCINNATI (WKRC) -Local doctors are among the first in the nation to use a new, implantable device to help save lives. It helps keep the heart beating strong. This new device could help reduce the ...
Medtronic has received U.S. regulatory approval to sell a new implantable defibrillator that can be placed outside of the heart and veins to treat SCA — sudden cardiac arrest — an electrical problem ...
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--AtaCor Medical, Inc. has announced completion of its second human clinical study of the Extravascular Implantable Cardioverter Defibrillator (EV-ICD) Lead System ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results